Zanganeh Mahkam Insider Trades

Insider Trading History

Track insider trading activity for Zanganeh Mahkam. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.65B 573,883,879 shares
Last Trade
Jun 12, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$50M 3,810,000 shares
$13.12
$15.07
Pulse Biosciences
Pulse Biosciences PLSE
Director
Holding Value $790k 30,000 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 44,504 shares
$26.89
$26.32
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $389M 25,824,474 shares
Last Trade
Jun 04, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.46M 100,000 shares
$14.60
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $169k 11,232 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$197k 11,232 shares
$17.52
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.59B 570,073,879 shares
Last Trade
Oct 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$267M 14,247,597 shares
$18.74
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $1.16M 76,680 shares
Last Trade
Oct 21, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$500k 26,680 shares
$18.74
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.38B 556,093,090 shares
Last Trade
Sep 11, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$90.4k 5,000 shares
$18.07
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.38B 556,088,090 shares
Last Trade
Sep 10, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.89M 333,394 shares
$17.68
$15.07
Pulse Biosciences
Pulse Biosciences PLSE
Director
Holding Value $790k 30,000 shares
Last Trade
Aug 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$875k 54,134 shares
$16.16
$26.32
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.38B 555,754,696 shares
Last Trade
May 30, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.36M 74,545 shares
$18.22
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $0 0 shares
Last Trade
May 30, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.36M 74,545 shares
$18.22
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $145M 9,590,558 shares
Last Trade
Apr 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$266M 11,030,558 shares
$24.11
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $8.37B 555,680,151 shares
Last Trade
Apr 08, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$66.3M 3,985,055 shares
$16.64
$15.07
Pulse Biosciences
Pulse Biosciences PLSE
Director
Holding Value $0 0 shares
Last Trade
Feb 03, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$614k 30,121 shares
$20.39
$26.32
Pulse Biosciences
Pulse Biosciences PLSE
Director
Holding Value $19.1M 725,395 shares
Last Trade
Feb 03, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$614k 30,121 shares
$20.39
$26.32
Pulse Biosciences
Pulse Biosciences PLSE
Director
Holding Value $18.3M 695,274 shares
Last Trade
Jan 24, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$546k 30,121 shares
$18.12
$26.32
Summit Therapeutics
Summit Therapeutics SMMT
10% owner, Co-chief Executive Officer
Holding Value $162k 10,724 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$197k 10,724 shares
$18.35
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
Co-chief Executive Officer
Holding Value $154M 10,199,776 shares
Last Trade
Oct 03, 2024 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$5.87M 315,681 shares
$18.61
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
Co-chief Executive Officer
Holding Value $0 0 shares
Last Trade
Oct 03, 2024 Sale (In The Money)Reported as In The Money on SEC Form 4.
$5.87M 315,681 shares
$18.61
$15.07
Summit Therapeutics
Summit Therapeutics SMMT
Co-chief Executive Officer
Holding Value $376M 24,967,852 shares
Last Trade
Sep 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 44,052 shares
$22.70
$15.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up